A Hormonal and Cell Cycle Centered Approach to Breast Cancer
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5922Keywords:
Cancer, Cell Cycle, Hormones, Estrogen, Progesterone, Mitosis, Breast Cancer, CDK-6, Cyclin, Indole - 3 - Carbinol, metastasis, Pregnancy, Triple Negative Breast Cancer, Luminal Breast Cancer, Tamoxifen, Chemotherapy, Hormone TherapyAbstract
In the year 2022 alone, almost 2 million new cancer cases have plagued just the United States, breast cancer being the most threatening for women (Łukasiewicz et al., 2021). It is important to advance our scientific understanding of cancer, to improve our surgical techniques, and to administer more efficient chemotherapy. While all of this is true, it is just as important to focus on prevention. To focus on the fundamental understandings of the cell cycle and hormones, and how they can play a major factor in preventing breast cancer. And to also focus on finding compounds like Indole 3 Carbinol which is present in our food, to teach us how certain environmental and lifestyle changes might keep us healthier for longer and prevent mutations in our cell cycles.
Downloads
References or Bibliography
References
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021). Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers, 13(17), 4287. https://doi.org/10.3390/cancers13174287
Yersal, O. (2014). Biological subtypes of breast cancer: Prognostic and therapeutic implications. World Journal of Clinical Oncology, 5(3), 412. https://doi.org/10.5306/wjco.v5.i3.412
Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF, Firestone GL. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem. 1998 Feb 13;273(7):3838-47. doi: 10.1074/jbc.273.7.3838. PMID: 9461564.
Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002 Jan 25;108(2):171-82. doi: 10.1016/s0092-8674(02)00615-3. PMID: 11832208.
Tufail M, Cui J, Wu C. Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches. Am J Cancer Res. 2022 Jul 15;12(7):2920-2949. PMID: 35968356; PMCID: PMC9360230.
Farrar MC, Jacobs TF. Tamoxifen. [Updated 2022 May 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532905/
BRCA: The breast cancer gene - BRCA mutations & risks. National Breast Cancer Foundation. (2022, October 25). https://www.nationalbreastcancer.org/what-is-brca/
MD Anderson Cancer Center, & Wendler, R. (2022, August 8). How does hormone therapy for breast cancer work?. MD Anderson Cancer Center. https://www.mdanderson.org/cancerwise/what-is-hormone-therapy-for-breast-cancer.h00-159542112.html
Santen, R. J., Stuenkel, C. A., & Yue, W. (2022). Mechanistic Effects of Estrogens on Breast Cancer. Cancer journal (Sudbury, Mass.), 28(3), 224–240. https://doi.org/10.1097/PPO.0000000000000596
Gompel A. (2019). Hormones et cancers du sein [Hormone and breast cancer]. Presse medicale (Paris, France : 1983), 48(10), 1085–1091. https://doi.org/10.1016/j.lpm.2019.09.021
Kim M. Y. (2021). Breast Cancer Metastasis. Advances in experimental medicine and biology, 1187, 183–204. https://doi.org/10.1007/978-981-32-9620-6_9
Piezzo, M., Cocco, S., Caputo, R., Cianniello, D., Gioia, G. D., Lauro, V. D., Fusco, G., Martinelli, C., Nuzzo, F., Pensabene, M., & De Laurentiis, M. (2020). Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors. International journal of molecular sciences, 21(18), 6479. https://doi.org/10.3390/ijms21186479
Schafer K. A. (1998). The cell cycle: a review, 35(6), 461–478. https://doi.org/10.1177/030098589803500601
Murray A. (1994). Cell cycle checkpoints. Current opinion in cell biology, 6(6), 872–876. https://doi.org/10.1016/0955-0674(94)90059-0
Russo, J., Mailo, D., Hu, Y. F., Balogh, G., Sheriff, F., & Russo, I. H. (2005). Breast differentiation and its implication in cancer prevention. Clinical cancer research : an official journal of the American Association for Cancer Research, 11(2 Pt 2), 931s–6s.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Amrita Guha; Haley Dame
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.